{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:13:17Z","timestamp":1773270797236,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Science and Technology Major Project","award":["2013ZX09402203"],"award-info":[{"award-number":["2013ZX09402203"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bmcl.2017.07.016","type":"journal-article","created":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T15:00:17Z","timestamp":1499266817000},"page":"3688-3692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Discovery of a potent angiotensin converting enzyme inhibitor via virtual screening"],"prefix":"10.1016","volume":"27","author":[{"given":"Zhipeng","family":"Ke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenzhen","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinzhuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7454-2238","authenticated-orcid":false,"given":"Gang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenzhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haichun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2017.07.016_b0005","doi-asserted-by":"crossref","first-page":"11832","DOI":"10.1021\/jf404641v","article-title":"Angiotensin-converting enzyme inhibitory effects by plant phenolic compounds: a study of structure activity relationships","volume":"61","author":"Al","year":"2013","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.bmcl.2017.07.016_b0010","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1590\/S0100-879X2004000800018","article-title":"Reactive oxygen species and angiotensin II signaling in vascular cells \u2013 implications in cardiovascular disease","volume":"37","author":"Touyz","year":"2004","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.bmcl.2017.07.016_b0015","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nature01370","article-title":"Crystal structure of the human angiotensin-converting enzyme-lisinopril complex","volume":"421","author":"Natesh","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2017.07.016_b0020","first-page":"11","article-title":"Angiotensin converting enzyme inhibitors in hypertension: potential problems","volume":"13","author":"Antonios","year":"1995","journal-title":"J Hypertens Suppl Off J Int Soc Hypertens"},{"key":"10.1016\/j.bmcl.2017.07.016_b0025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7326\/0003-4819-117-3-234","article-title":"Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology","volume":"117","author":"Israili","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bmcl.2017.07.016_b0030","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1016\/j.bmcl.2006.06.004","article-title":"Synthesis and molecular modeling of a lisinopril-tryptophan analogue inhibitor of angiotensin I-converting enzyme","volume":"16","author":"Nchinda","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2017.07.016_b0035","first-page":"1","article-title":"Antibacterial properties of plant species native to the New Jersey pinelands","volume":"50","author":"Errickson","year":"2005","journal-title":"New Jersey Acad Sci"},{"key":"10.1016\/j.bmcl.2017.07.016_b0040","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2174\/138620710793360239","article-title":"Screening of enzyme inhibitors from traditional Chinese medicine","volume":"13","author":"Shen","year":"2010","journal-title":"Comb Chem High Throughput Screening"},{"key":"10.1016\/j.bmcl.2017.07.016_b0045","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1590\/S0102-695X2006000300021","article-title":"Natural products inhibitors of the angiotensin converting enzyme (ACE): a review between 1980\u20132000","volume":"16","author":"Barbosa-Filho","year":"2006","journal-title":"Rev Bras Farmacognosia"},{"key":"10.1016\/j.bmcl.2017.07.016_b0050","article-title":"Study on angiotensin converting enzyme inhibition activity and active ingredient of traditional Chinese medicines","author":"Xiao-Duo","year":"2013","journal-title":"Sci Technol Food Ind"},{"key":"10.1016\/j.bmcl.2017.07.016_b0055","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jep.2014.05.066","article-title":"Traditional Chinese herbs as chemical resource library for drug discovery of anti-infective and anti-inflammatory","volume":"155","author":"Ding","year":"2014","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.bmcl.2017.07.016_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-61779-012-6_1","article-title":"Virtual screening for lead discovery","volume":"716","author":"Tang","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bmcl.2017.07.016_b0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/138955708783331540","article-title":"Essential factors for successful virtual screening","volume":"8","author":"Seifert","year":"2008","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.bmcl.2017.07.016_b0070","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1155\/2013\/425707","article-title":"Platelet aggregation pathway network-based approach for evaluating compounds efficacy","volume":"2013","author":"Gu","year":"2013","journal-title":"Evidence-Based Complement Altern Med"},{"key":"10.1016\/j.bmcl.2017.07.016_b0075","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.biopha.2016.01.021","article-title":"Drug discovery of neurodegenerative disease through network pharmacology approach in herbs","volume":"78","author":"Ke","year":"2016","journal-title":"Biomed Pharmacother"},{"issue":"Database issue","key":"10.1016\/j.bmcl.2017.07.016_b0080","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"Wishart","year":"2006","journal-title":"Nucleic Acids Res"},{"issue":"Suppl. 1","key":"10.1016\/j.bmcl.2017.07.016_b0085","first-page":"1","article-title":"Structural insights into mode of actions of novel natural Mycobacterium protein tyrosine phosphatase B inhibitors","volume":"15","author":"Dhanjal","year":"2014","journal-title":"BMC Genomics"},{"key":"10.1016\/j.bmcl.2017.07.016_b0090","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1021\/bi049480n","article-title":"Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme","volume":"43","author":"Natesh","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmcl.2017.07.016_b0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/pauz.200390001","article-title":"From teprotide to captopril. Rational design of ACE inhibitors","volume":"32","author":"Nemec","year":"2003","journal-title":"Pharm Unserer Zeit"},{"key":"10.1016\/j.bmcl.2017.07.016_b0100","first-page":"159","article-title":"American society of health-system pharmacists","volume":"36","author":"Lee","year":"2011","journal-title":"P & T"},{"key":"10.1016\/j.bmcl.2017.07.016_b0105","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s40064-016-1972-4","article-title":"CrossDocker: a tool for performing cross-docking using Autodock Vina","volume":"5","author":"Shamsara","year":"2016","journal-title":"SpringerPlus"},{"key":"10.1016\/j.bmcl.2017.07.016_b0110","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/ci7004274","article-title":"ChemInform abstract: cross-docking of inhibitors into CDK2 structures. Part 1","volume":"48","author":"Duca","year":"2008","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmcl.2017.07.016_b0115","article-title":"Pharmacophore modeling and virtual screening studies to identify new c-Met inhibitors","author":"Tai","year":"2011","journal-title":"J Mol Model"},{"key":"10.1016\/j.bmcl.2017.07.016_b0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.molstruc.2014.03.036","article-title":"3D-QSAR and molecular fragment replacement study on diaminopyrimidine and pyrrolotriazine ALK inhibitors","volume":"1067","author":"Ke","year":"2014","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmcl.2017.07.016_b0125","author":"Marsilje","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.07.016_b0130","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s11030-012-9405-y","article-title":"De novo design of N-(pyridin-4-ylmethyl)aniline derivatives as KDR inhibitors: 3D-QSAR, molecular fragment replacement, protein-ligand interaction fingerprint, and ADMET prediction","volume":"16","author":"Zhang","year":"2012","journal-title":"Mol Diversity"},{"key":"10.1016\/j.bmcl.2017.07.016_b0135","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1080\/1062936X.2013.815655","article-title":"Molecular modelling on small molecular CDK2 inhibitors: an integrated approach using a combination of molecular docking, 3D-QSAR and pharmacophore modelling","volume":"24","author":"Yuan","year":"2013","journal-title":"SAR QSAR Environ Res"},{"key":"10.1016\/j.bmcl.2017.07.016_b0140","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1021\/ci6004993","article-title":"Supervised consensus scoring for docking and virtual screening","volume":"47","author":"Teramoto","year":"2007","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmcl.2017.07.016_b0145","first-page":"1","article-title":"Virtual screening in drug design","volume":"Vol. 993","author":"Lill","year":"2013"},{"key":"10.1016\/j.bmcl.2017.07.016_b0150","doi-asserted-by":"crossref","first-page":"16023","DOI":"10.1038\/npjsba.2016.23","article-title":"Molecular mechanisms involved in the side effects of fatty acid amide hydrolase inhibitors: a structural phenomics approach to proteome-wide cellular off-target deconvolution and disease association","volume":"2","author":"Dider","year":"2016","journal-title":"NPJ Syst Biol Appl"},{"key":"10.1016\/j.bmcl.2017.07.016_b0155","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/00005344-198911000-00009","article-title":"Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology","volume":"14","author":"DeForrest","year":"1989","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.bmcl.2017.07.016_b0160","series-title":"Discovery Studio Modeling Environment, Release 4.5","author":"Syst\u00e8mes","year":"2015"},{"key":"10.1016\/j.bmcl.2017.07.016_b0165","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1210\/en.2007-1628","article-title":"Endothelin-converting enzyme-1 degrades internalized somatostatin-14","volume":"149","author":"Roosterman","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.bmcl.2017.07.016_b0170","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbrc.2004.07.094","article-title":"Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells","volume":"322","author":"Fu","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmcl.2017.07.016_b0175","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1055\/s-2002-32087","article-title":"In vitro antimycobacterial and antilegionella activity of licochalcone A from Chinese licorice roots","volume":"68","author":"Friis-M\u00f8ller","year":"2002","journal-title":"Planta Med"},{"key":"10.1016\/j.bmcl.2017.07.016_b0180","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.intimp.2009.01.031","article-title":"Glycyrrhiza inflata-derived chalcones, Licochalcone A, Licochalcone B and Licochalcone D, inhibit phosphorylation of NF-kappaB p65 in LPS signaling pathway","volume":"9","author":"Furusawa","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.bmcl.2017.07.016_b0185","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1128\/AAC.38.7.1470","article-title":"Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection","volume":"38","author":"Chen","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2017.07.016_b0190","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bmcl.2010.11.016","article-title":"Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata","volume":"21","author":"Dao","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2017.07.016_b0195","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3892\/ijo.2014.2461","article-title":"Licochalcone A, a natural chalconoid isolated from Glycyrrhiza inflata root, induces apoptosis via Sp1 and Sp1 regulatory proteins in oral squamous cell carcinoma","volume":"45","author":"Cho","year":"2014","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bmcl.2017.07.016_b0200","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.phrs.2016.10.026","article-title":"Systems-biology dissection of mechanisms and chemical basis of herbal formula in treating chronic myocardial ischemia","volume":"114","author":"Guo","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bmcl.2017.07.016_b0205","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jnatprod.5b00877","article-title":"Bioactive constituents of Glycyrrhiza uralensis (Licorice): discovery of the effective components of a traditional herbal medicine","volume":"79","author":"Ji","year":"2016","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmcl.2017.07.016_b0210","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0031-9422(97)01105-9","article-title":"Mode of antibacterial action of retrochalcones from Glycyrrhiza inflata","volume":"48","author":"Haraguchi","year":"1998","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bmcl.2017.07.016_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-016-0294-3","article-title":"Cardioprotection provided by Echinatin against ischemia\/reperfusion in isolated rat hearts","volume":"16","author":"Tian","year":"2016","journal-title":"BMC Cardiovasc Disorders"},{"key":"10.1016\/j.bmcl.2017.07.016_b0220","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.bcp.2011.07.093","article-title":"Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications","volume":"82","author":"Singh","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmcl.2017.07.016_b0225","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.phytochem.2006.06.020","article-title":"Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives","volume":"67","author":"Nagle","year":"2006","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bmcl.2017.07.016_b0230","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/bph.12009","article-title":"Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea","volume":"168","author":"Steinmann","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmcl.2017.07.016_b0235","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12937-016-0179-4","article-title":"Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)","volume":"15","author":"Singh","year":"2016","journal-title":"Nutr J"},{"key":"10.1016\/j.bmcl.2017.07.016_b0240","doi-asserted-by":"crossref","first-page":"366S","DOI":"10.1080\/07315724.2007.10719625","article-title":"Effects of flavonoid-containing beverages and EGCG on endothelial function","volume":"26","author":"Shenouda","year":"2007","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.bmcl.2017.07.016_b0245","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.phrs.2010.12.013","article-title":"Weight control and prevention of metabolic syndrome by green tea","volume":"64","author":"Sae-tan","year":"2011","journal-title":"Pharmacol Res"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X17307047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X17307047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:17:35Z","timestamp":1760771855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X17307047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":49,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0960894X17307047"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2017.07.016","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a potent angiotensin converting enzyme inhibitor via virtual screening","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2017.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}